Supplementation of the diets of rats with branched chain amino acids (BCAA: leucine, isoleucine, valine) did not alter their susceptibility to chronic poisoning by tansy ragwort (Senecio jacobaea), which contains heptotoxic pyrrolizidine alkaloids (PA). Phenobarbital in the diet, which alters liver microsomal enzyme activity, also did not alter susceptibility to PA poisoning. A combination of butylated hydroxyanisole (BHA), cysteine and BCAA did increase (P<.05) survival time of rats fed tansy ragwort. Dietary BHA and cysteine increased the survival time of rats injected with the PA monocrotaline, with evidence that addition of vitamin B12 and folic acid improved the effectiveness of this treatment. In a chronic feeding trial with tansy ragwort, a combination of BHA and cysteine increased (P<.05) the survival times of rats, showing protective activity against PA poisoning. A mixture of B-complex vitamins, or vitamin B12-folic acid, was not effective in improving the response.
react with hepatic macromolecules, causing liver necrosis (White et al., 1973) .
Cattle and horses are the major livestock species affected by tansy ragwort poisoning. Some animals like sheep and goats are resistant to PA (Goeger et al., 1982) probably because of the nature of their hepatic metabolism Swick et al., 1983) . Supplementation of susceptible animal species with dietary additives that modify liver metabolism might be a feasible way of increasing their resistance to Senecio toxicity. Cysteine , butylated hydroxyanisole (BHA; Miranda et al., 1981) and branched-chain amino acids (BCAA; Rogers et al., 1979) have shown protective action against PA toxicity. Therefore, the objective of this study was to evaluate Carious types of dietary supplements to determine if animals susceptible to PA poisoning could be rendered more resistant, as a model for developing dietary supplements for use in protecting large animals from PA poisoning.
Materials and Methods
Tansy ragwort in full bloom was collected in the vicinity of Corvallis, Oregon. The plant material was dried at 45 C, ground in a Wiley mill and stored at room temperature. Statistical analysis of data involved one-way analysis of variance with treatments compared with appropriate controls by least significant difference (Steel and Torrie, 1960) . Means + SE are presented in the tables. The amino acids used were DL, except for cysteine; L-cysteine was used.
Exp. 1. The objectives of this experiment were to determine if various dietary supplements modified the susceptibility of rats to tansy ragwort poisoning, as assessed by growth and survival time.
Sixty male Sprague-Dawley rats of approximately 117 g initial weight were distributed 138 JOURNAL OF ANIMAL SCIENCE, Vol. 58, No. 1, 1984 randomly into 12 treatments of five rats each. Dietary treatments were as follows: 1) control, 2) basal (control + 5% tansy ragwort), 3) basal +~ .15% phenobarbital (PB), 4) basal + .75% BHA, 5) basal + 1% cysteine, 6) basal + 3% branched-chain amino acids (BCAA--1% leucine, 1% isoleucine, 1% valine), 7) basal + .15% PB + BCAA, 8) basal + 3% BCAA + 1% cysteine, 9) basal + 3% BCAA + 1% cysteine + .15% PB, 10) basal + 3% BCAA + 1% cysteine + .75% BHA, 11) basal + 3% BCAA + 1% cysteine + .75% BHA + .15% PB, and 12) basal + 1% phenylalanine + 1% tyrosine.
The basal diet was that of Miranda et al. (1980) . All substances were added in place of the complete diet (e.g., 92% control, 5% tansy ragwort, 3% BCAA). Rats were caged individually in galvanized cages and fed and watered ad libitum. Feeders were weighed three times per week for determination of feed intake. The diets with the additives were fed for a 1-wk pretreatment period before the tansy ragwort was added, to allow hepatic enzyme induction before exposure to PA.
Exp. 2.
The results of Exp. 1 suggested protective activity against PA toxicity for some of the additives. The objective of this experiment was to evaluate the effects of B vitamins on the responses to cysteine and BHA. Sixtyfive male Sprague-Dawley rats of about 100 g initial weight were distributed randomly into the 12 treatments of five rats each. The animals were fed their respective diets for 7 d and then were given a series of ip doses of the PA monocrotaline, which totalled 230 mg monocrotaline/ kg body weight. The following dietary treatments were used: 1) control (saline injected), 2) control (monocrotaline injected, MI), 3) control (MI) + 1% cysteine, 4) control (MI) + .75% BHA, 5) control (MI) + vitamin B12 + folic acid, 6) control (MI) + B vitamin mixture, 7) control (MI) + .75% BHA + 1% cysteine, 8) control (MI) + .75% BHA + 1% cysteine + B vitamin mixture, 9) control (MI) + .75% BHA + B12 + folic acid, 10) control (MI) + .75% BHA + B vitamin mixture, 11) control (MI) + 1% cysteine + B vitamin mixture, and 12) control (MI) + 1% cysteine + B12 + folic acid.
The compositions of the B vitamin mixture, and of the vitamin mixture used in the control diet, are shown in table 1. The vitamin mixtures were incorporated at 1% of the diet. Folic acid and vitamin BIz we/re fed at concentrations of 5 /ag/g and 200 r/g/g, respectively. The control diet had the following composition: ground corn, 61%; soybean meal, 32%; soybean oil, 3%, and Jones and Foster (1942) mineral mix, 4%. The test compounds, and either the basal or B vitamin mix, were added in place of the complete diet (e.g., 98% control, 1% cysteine, 1% basal vitamin mix).
The monocrotaline solution was prepared by dissolving the alkaloid in .2 N HC1, neutralizing with .2 N NaOH, and diluting to volume with saline. Multiple injections of monocrotaline were given to approximate chronic feeding doses. Dosages of 30 mg/kg were injected on d 7, 9, 11, 13 and 15; 20 mg/kg was injected on d 17, and 15 mg/kg on d 19, 21, 29 and 33. Animals in control group 1 received the vehicle Forty-two Sprague-Dawley rats of approximately 95 g were distributed randomly into seven treatments of six rats each. The control diet was that of Miranda et al. (1980) ; test substances were added in place of the complete diet. Treatments were as follows: 1) control, 2) control + 5% tansy ragwort (basal), 3) basal + vitamin B12-folic acid (200 r/g/g and 5 /~g/g, respectively), 4) basal + .75% BHA, 5) basal + .75% BHA + vitamin B12-folic acid, 6) basal + .75% BHA + 1% cysteine and 7) basal + .75% BHA + 1% cysteine + vitamin B12-folic acid.
Diets with additives were fed 7 d before the tansy ragwort was added. After 17 wk of tansy ragwort exposure, the diets were fed for 6 wk without tansy ragwort; for the remainder of the experiment, the surviving rats were fed Purina Rat Chow ad libitum. All surviving rats were killed on d 307.
Results
Exp. 1. The PB treatment did not affect survival times (P>.05) of rats fed tansy ragwort, but in each case that PB was used, survival time was slightly less than in similar treatments without its addition (table 2). The BCAA had no effect (P<.05) on survival time. Evidence of protective activity against PA toxicity was observed in the treatments with cysteine, BHA and BCAA, in which increased survival time occurred (table 2) . This may be due to an interaction of BHA and cysteine. The BHA is an inducer of glutathione-S-transferase in mice (Miranda et al., 1981) , while cysteine is a precursor of glutathione, so the combined treatment could allow increased conjugation of PA metabolites.
Exp. 2.
The longest survival times were with the treatments with BHA and cysteine, with or without vitamin B12-folic acid (table 3). There was evidence that the vitamin B12-folic acid may have had some influence on PA metabolism because at d 42, all rats on cysteine + vitamin B12-folic acid were still alive, while mortality had occurred in all other treatments (table 3) . It is likely that the dosage of monocrotaline given substantially exceeded the lethal dose, as there can be a large lag time between intake of PA and mortality (Swick et al., 1979 
Discussion
This study has demonstrated that a combination of cysteine and BHA has protective activity in rats against PA toxicity. The probable mechanism of * action is that BHA stimulates glutathione-S-transferase activity, while cysteine provides a precursor for glutathione synthesis. These favorable results warrant evaluation of the protective agent mixture with cattle and horses. Cysteine is not available commercially at an economical price, so an alternative precursor would be needed. One possibility is methionine, which can be converted to cysteine in vivo. For cattle, methionine hydroxy analog, which is more resistant to ruminal degradation than methionine, might be useful.
The BCAA (leucine, isoleucine, valine) were used in this study to test the suggestion of Rogers et al. (1979) that they have protective activity against PA toxicity. The inclusion of BCAA had no effect on survival time of rats, which does not support the proposed protective effects suggested by Rogers et al. (1979) . Rosen et al. (1977) , Cascino et al. (1978) and Gulick et al. (1980) reported that in various species, similar changes in plasma amino acid patterns are seen in animals with hepatic disease. Neurological improvement and increased survival time have been reported in man when plasma amino acid pattern was restored toward normal by supplementations with the appropriate amino acids (Fischer et al., 1975 (Fischer et al., , 1976 . Rogers et al. (1979) reported that treatment of a horse poisoned by PA with a paste of BCAA restored its normal plasma amino acid pattern and improved its physical condition. The aromatic amino acids, phenyl o anine and tyrosine, increased as the BCAA plasma concentrations decreased during hepatic disease. The aromatic amino acids are neurotransmitter precursors. These observations may relate to the hypothesis by which James et al. (1979) related encephalopathy and hepatic coma to liver damage. When liver function is reduced, the blood ammonia level may stimulate the secretion of glucagon which in turn may cause a high insulin secretion. Insulin stimulates the uptake and catabolism of the BCAA leucine, isoleucine and valine, by muscle. The entry into the brain of the aromatic amino acids may be enhanced because of less competition due to the lowered BCAA level in the plasma. The level of these neurotransmitter precursors could alter the balance of neurotransmitter substances in the brain and cause hepatic encephalopathy. Thus it was hypothesized that feeding an elevated level o~ aromatic amino acids might increase tansy ragwort toxicity and decrease stlvival time. This did not occur (table 2) . phenobarbital was used as a hepatic drugmtaDolizing enzyme inducer to determine if it inlaenced the susceptibility of rats to tansy ra~,ort toxicity. For example, guinea pigs are ratant to the toxic effects of the PA monoc~taline (Swick et al., 1982a) , but if they are pttreated with PB, they become susceptible, de to increased liver pyrrole production rate (Chesney and Allen, 1973) . Allen et al. (1972) found that after stimulation of microsomal enzymes with PB, rats died more rapidly than those that received monocrotaline alone. Phenobarbital also increased the susceptibility of guinea pigs to the acute hepatoxic effects of the PA retrorsine (White et al., 1973) . The lack of effect of PB on tansy ragwort toxicity in rats might be a result of induction of enzymes involved in PA conjugation and excretion, as well as pyrrole production. Also, the effects of PB may vary according to the specific PA involved.
High concentrations of B vitamins were tested, as they are coenzymes in various enzymatic reactions related to the biological effects of PA. Vitamin B12 and folic acid were of particular interest, as they are involved in hematopoesis. Pronounced anemia and impaired red blood cell formation occurs in PA poisoning (Swick et al., 1982b) , suggesting that vitamin B12 and folic acid could have a possible effect in ameliorating these effects. However, there was little response to increased levels of these vitamins in rats fed tansy ragwort or injected with monocrotaline.
The results of this research indicate that a combination of cysteine and BHA has protective effects against PA toxicity in rats. Based on these findings, studies with cattle and horses to evaluate the possible protective activity of these compounds against tansy ragwort toxicity would be useful.
